See all news

STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum

  • 2014-11-17
  • Press release

MONROVIA, Calif., Nov. 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum in New York at the Westin Grand Central on Thursday, November 20 at 12:30 p.m. PT/3:30 p.m. ET.

STAAR management will present a general overview of the Company's current business trends, financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentation will be available for 90 days following the event, also at

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 475,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at




EVC Group

 EVC Group

Brian Moore, 310-579-6199

 Nicole Kruse, 212-850-6025

Doug Sherk, 415-652-9100


SOURCE STAAR Surgical Company